Demographics and comorbidity |
|
|
|
|
|
Age, year |
64.8±10.0 |
61.9±8.7 |
65.4±10.1 |
65.9±10.3 |
0.128 |
Female gender, n (%) |
52 (33.8) |
16 (44.4) |
16 (38.1) |
20 (26.3) |
0.130 |
Body mass index |
29.0±6.2 |
28.5±6.7 |
30.5±6.7 |
28.3±5.7 |
0.245 |
Hypercholesterolemia, n (%) |
31 (24.0) |
6 (16.7) |
10 (28.6) |
15 (25.9) |
0.456 |
Diabetes mellitus, n (%) |
84 (54.5) |
19 (52.8) |
25 (59.5) |
40 (52.6) |
0.749 |
Chronic obstructive lung disease, n (%) |
9 (5.8) |
2 (5.6) |
2 (4.8) |
5 (6.6) |
0.919 |
Peripheral vascular disease, n (%) |
6 (3.9) |
0 (0) |
2 (4.8) |
4 (5.3) |
0.382 |
End stage renal failure, n (%) |
5 (3.2) |
2 (5.6) |
2 (4.8) |
1 (1.3) |
0.403 |
Cerebrovascular accident, n (%) |
16 (10.4) |
3 (8.3) |
4 (9.5) |
9 (11.8) |
0.831 |
Myocardial infarction, n (%) |
64 (41.6) |
15 (41.7) |
22 (52.4) |
27 (35.5) |
0.206 |
Percutaneous coronary intervention, n (%) |
36 (23.4) |
14 (38.9) |
10 (23.8) |
12 (15.8) |
0.026 |
Euro score II |
3.0±4.0 |
2.1±1.4 |
2.8±4.1 |
3.5±4.6 |
0.213 |
Angiographic findings |
|
|
|
|
|
Number of diseased coronary vessels |
2.7±0.54 |
2.2±0.68 |
2.8±0.46 |
2.9±0.33 |
<0.001 |
Left main disease, n (%) |
55 (35.7) |
13 (36.1) |
7 (16.7) |
35 (46.1) |
0.006 |
SYNTAX score |
30.8±10.8 |
16.6±4.7 |
27.1±3.0 |
39.5±6.5 |
<0.001 |
Ejection fraction, % |
51.9±12.4 |
55.0±10.0 |
51.1±12.7 |
50.8±13.1 |
0.224 |